SEPTInvestingStart Free

TRIB SCHEDULE 13D/A: SEC filing

Perceptive Advisors LLC

Filed with the SEC on · accession 0001193125-26-455946

TRIB filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Nov 10, 2026. Perceptive Advisors LLC filed an amended Schedule 13D reporting beneficial ownership of approximately 9.99% of Trinity Biotech plc, consisting of warrants, a convertible note, and milestone/contingent payment obligations convertible into ordinary shares/ADSs.

Summary of the filing

Perceptive Advisors LLC filed an amended Schedule 13D reporting beneficial ownership of approximately 9.99% of Trinity Biotech plc, consisting of warrants, a convertible note, and milestone/contingent payment obligations convertible into ordinary shares/ADSs. The filing reflects the reporting person's existing position and related conversion rights rather than a new acquisition event.

For details, click here →

Key details

Ordinary shares beneficially owned (as reported, subject to beneficial ownership cap)$54.1M
Ordinary shares issuable upon exercise of warrants$65.0M
Ordinary shares underlying convertible note (represented by ADSs)$4.3B
Ordinary shares underlying milestone payment obligation$300.0M
Ordinary shares underlying contingent payment obligation$431.9M
Reporting person / beneficial ownerPerceptive Advisors LLC
Holder of warrants and payment obligationsPerceptive Credit Holdings II, LP
Holder of warrants and convertible notePerceptive Credit Holdings III, LP
Issuer / subject companyTrinity Biotech plc
Reporting person / control person of perceptive advisorsJoseph Edelman
Contact for perceptive advisorsAlexander Rakitin

✦ Ask GOAX AI about this filing — what it means for TRIB, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for TRIB?

Click here

Frequently asked questions

What did TRIB file with the SEC on Nov 10, 2026?

TRIB filed a SCHEDULE 13D/A (SEC filing). Perceptive Advisors LLC filed an amended Schedule 13D reporting beneficial ownership of approximately 9.99% of Trinity Biotech plc, consisting of warrants, a convertible note, and milestone/contingent payment obligations convertible into ordinary shares/ADSs. The filing reflects the reporting person's existing position and related conversion rights rather than a new acquisition event.

How do I read a SCHEDULE 13D/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).

Other TRIB SEC filings

Get alerts when TRIB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
TRIB overviewTRIB analysisTRIB newsLatest SEC filings